Tripacel
Details for Tripacel vaccine and its components.
Sponsor:
Sanofi-Aventis Australia
Administration route:
Intramuscular injection
Vaccine group:
Combination vaccines
Registered for primary immunisation in infants aged 2–12 months and as a booster in children aged 15 months to 8 years.
DTPa — diphtheria-tetanus-acellular pertussis combination vaccine
Each 0.5 mL monodose vial contains:
- ≥30 IU diphtheria toxoid
- ≥40 IU tetanus toxoid
- 10 µg pertussis toxoid
- 5 µg filamentous haemagglutinin
- 3 µg pertactin
- 5 µg pertussis fimbriae types 2 and 3
- 1.5 mg aluminium phosphate
- 0.6% v/v phenoxyethanol
For full details, refer to the product information and consumer medicine information sheets for Tripacel vaccine available on the TGA website.
Page history
Last updated:
4 June 2018
Last reviewed:
4 June 2018
Definitions
- DTPa
- diphtheria-tetanus-acellular pertussis vaccine
- IU
- international units
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/tripacel.